Triamcinolone acetonide extended-release injectable suspension (TA-ER) provides clinically relevant improvements in pain and function of knee osteoarthritis: a pooled analysis of 3 randomized clinical trials employing composite assessments
Publication
, Conference
Katz, NP; Conaghan, PG; Kraus, VB; Lufkin, J; Johnson, JR; Kelley, S
Published in: Osteoarthritis and Cartilage
April 2018
Duke Scholars
Published In
Osteoarthritis and Cartilage
DOI
ISSN
1063-4584
Publication Date
April 2018
Volume
26
Start / End Page
S232 / S233
Publisher
Elsevier BV
Related Subject Headings
- Arthritis & Rheumatology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 1106 Human Movement and Sports Sciences
- 1103 Clinical Sciences
- 0903 Biomedical Engineering
Citation
APA
Chicago
ICMJE
MLA
NLM
Katz, N. P., Conaghan, P. G., Kraus, V. B., Lufkin, J., Johnson, J. R., & Kelley, S. (2018). Triamcinolone acetonide extended-release injectable suspension (TA-ER) provides clinically relevant improvements in pain and function of knee osteoarthritis: a pooled analysis of 3 randomized clinical trials employing composite assessments. In Osteoarthritis and Cartilage (Vol. 26, pp. S232–S233). Elsevier BV. https://doi.org/10.1016/j.joca.2018.02.485
Katz, N. P., P. G. Conaghan, V. B. Kraus, J. Lufkin, J. R. Johnson, and S. Kelley. “Triamcinolone acetonide extended-release injectable suspension (TA-ER) provides clinically relevant improvements in pain and function of knee osteoarthritis: a pooled analysis of 3 randomized clinical trials employing composite assessments.” In Osteoarthritis and Cartilage, 26:S232–33. Elsevier BV, 2018. https://doi.org/10.1016/j.joca.2018.02.485.
Katz NP, Conaghan PG, Kraus VB, Lufkin J, Johnson JR, Kelley S. Triamcinolone acetonide extended-release injectable suspension (TA-ER) provides clinically relevant improvements in pain and function of knee osteoarthritis: a pooled analysis of 3 randomized clinical trials employing composite assessments. In: Osteoarthritis and Cartilage. Elsevier BV; 2018. p. S232–3.
Katz, N. P., et al. “Triamcinolone acetonide extended-release injectable suspension (TA-ER) provides clinically relevant improvements in pain and function of knee osteoarthritis: a pooled analysis of 3 randomized clinical trials employing composite assessments.” Osteoarthritis and Cartilage, vol. 26, Elsevier BV, 2018, pp. S232–33. Crossref, doi:10.1016/j.joca.2018.02.485.
Katz NP, Conaghan PG, Kraus VB, Lufkin J, Johnson JR, Kelley S. Triamcinolone acetonide extended-release injectable suspension (TA-ER) provides clinically relevant improvements in pain and function of knee osteoarthritis: a pooled analysis of 3 randomized clinical trials employing composite assessments. Osteoarthritis and Cartilage. Elsevier BV; 2018. p. S232–S233.
Published In
Osteoarthritis and Cartilage
DOI
ISSN
1063-4584
Publication Date
April 2018
Volume
26
Start / End Page
S232 / S233
Publisher
Elsevier BV
Related Subject Headings
- Arthritis & Rheumatology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 1106 Human Movement and Sports Sciences
- 1103 Clinical Sciences
- 0903 Biomedical Engineering